Cargando…
Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets
The topoisomerase I (Top 1) poison irinotecan is an important component of the modern treatment of colorectal cancer. By stabilising Top 1-DNA complexes, irinotecan generates Top 1-linked DNA single-strand breaks that can evolve into double-strand breaks and ultimately cause cell death. However, can...
Autores principales: | Gilbert, D C, Chalmers, A J, El-Khamisy, S F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251848/ https://www.ncbi.nlm.nih.gov/pubmed/22108516 http://dx.doi.org/10.1038/bjc.2011.498 |
Ejemplares similares
-
Therapeutic challenge for immunotherapy targeting cold colorectal cancer: A narrative review
por: Ma, Shi-Xun, et al.
Publicado: (2023) -
CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer
por: Cabrero-de las Heras, Sara, et al.
Publicado: (2018) -
Go-Ichi-Ni-San 2: A potential biomarker and therapeutic target in human cancers
por: Shan, Dan-Dan, et al.
Publicado: (2022) -
Cancer heterogeneity: implications for targeted therapeutics
por: Fisher, R, et al.
Publicado: (2013) -
Targeting telomerase for cancer therapeutics
por: Shay, J W, et al.
Publicado: (2008)